FDA Drug Application (021817) for RECLAST by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021817
Product Number001
FormINJECTABLE;IV (INFUSION)
DosageEQ 5MG BASE/100ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameRECLAST
Active IngredientZOLEDRONIC ACID

Active IngredientCount
List of drugs with Active Ingredient ZOLEDRONIC ACID3


Back to FDA Applications sponsored by NOVARTIS